登入選單
返回Google圖書搜尋
註釋Low molecular weight heparin, prepared by fractionation or depolarization of heparin, is a new and improved version of heparin, with greatly enhanced bioavailability and superior efficacy in some clinical conditions. The authors have been closely involved in the development, experimental study and standarization of low molecular weight heparin for the past 15 years. All aspects of low molecular weight heparin are covered including its chemistry, methods of production and analysis, mechanism of action, interaction with cells, animal and human pharmacology and clinical use.